Research Project
Grant-in-Aid for Scientific Research (C)
It has been shown that tumor suppressor gene, p53, is mutated in various gastrointestinal (GI) cancers. Loss of function of p53 exerts tumor development and progression, therefore restoration of p53 function might be useful for cancer treatment. CP31398 has developed for restoration of mutated p53 by modifying DNA-binding domain where frequently observed mutation in various cancers. We utilized CP31398 for a novel strategy for cancer treatment combined with modified (activated) p53. We tested mutant p53 and wild-type p53 expressing GI cancer cell lines with CP31398 with or without modified p53 transduction. As a result, CP31398 could enhance the cytotoxicity of modified p53 in SW480 cells possibly by induction of proapoptotic gene in a p53-dependent manner. This novel strategy will be a promising approach for GI cancer treatment.
All 2005 2004 2003 Other
All Journal Article (32 results)
Exp Hematol. 33
Pages: 1544-53
Leukemia. 19
Pages: 558-66
Cancer Biol Ther. 4
Pages: 421-8
Pages: 490-5
Blood. 106
Pages: 756-63
Pages: 1544-1553
Pages: 1558-1566
Intern Med. 44
Pages: 490-495
Pages: 421-428
Pages: 756-763
Br J Haematol. 124
Pages: 211-20
Blood 15;104(4)
Pages: 1002-9
Clin Cancer Res 1;10(23)
Pages: 7934-40
J Immunol 173
Pages: 285-96
Pages: 211-220
Blood. 104
Pages: 1002-1009
Clin Cancer Res. 10
Pages: 7934-7940
J Immunol. 173
Pages: 285-296
Clin Cancer Res. 1;10(23)
Gan To Kagaku Ryoho 31(9)
Pages: 1309-1313
J Immunol. 1;173(1)
Alcohol Clin Exp Res. 8 Suppl
Exp Hematol. 31
Pages: 715-22
Cancer Res. 63
Pages: 8948-54
Clin Cancer Res. 9
Pages: 4852-9
Pages: 715-722
Pages: 8948-8954
Pages: 4852-4859
Cancer Biol Ther. 2005 Apr.(in press)